Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Disc Medicine, Inc.IRON · Entity 2273 | Chief Medical Officer | April 13, 2026 | April 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Disc Medicine, Inc.
Report date April 13, 2026 · Filed April 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,480 |
Ending reported balance
After 2026-04-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-13 · Sale · Disposed 3,531 · Balance 81,680 F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Row 2 · 2026-04-13 · Sale · Disposed 2,200 · Balance 79,480 F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2023 Filed Aug 22, 2023 20:06 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 3,000 | $2.65 | $7,950.00 |
DisclosureSEC source: 0000950170-23-043894 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,839 | $53.96 | $99,240.16 |
DisclosureSEC source: 0000950170-23-043013 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.78 to $54.13, inclusive. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,125 | $53.26 | $113,175.16 |
DisclosureSEC source: 0000950170-23-043013 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,839 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.75 to $53.74, inclusive. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,708 | $52.27 | $193,819.76 |
DisclosureSEC source: 0000950170-23-043013 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,964 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.70 to $52.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,481 | $50.91 | $75,400.97 |
DisclosureSEC source: 0000950170-23-041865 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,672 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.58 to $51.31, inclusive. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,588 | $50.22 | $180,182.18 |
DisclosureSEC source: 0000950170-23-041865 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,153 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.58 to $50.57, inclusive. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,200 | $48.90 | $156,480.96 |
DisclosureSEC source: 0000950170-23-041865 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,741 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.44 to $49.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:12 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,564 | $50.72 | $79,327.17 |
DisclosureSEC source: 0000950170-23-031110 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,941 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.53 to $51.28, inclusive. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:12 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,300 | $50.00 | $65,003.90 |
DisclosureSEC source: 0000950170-23-031110 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,505 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.52 to $50.51, inclusive. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:12 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,520 | $49.20 | $74,782.63 |
DisclosureSEC source: 0000950170-23-031110 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,805 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.52 to $49.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 22:05 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 38,924 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000899243-23-000298 · doc4.xml · derivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,924 Underlying: Common Stock · 38,924 shares Expires 2032-12-28 F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.